1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Peripheral Nerve Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, S; Inoue, K; Ishii, S; Kohro, Y; Shimizu, T; Shiratori, M; Tsuda, M | 1 |
| Dohi, T; Kanematsu, T; Kitayama, T; Morita, K; Motoyama, N; Nishimura, F; Shiraishi, S; Uezono, Y | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Peripheral Nerve Injuries
| Article | Year |
|---|---|
Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain.
Topics: 1-Acylglycerol-3-Phosphate O-Acyltransferase; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Ganglia, Spinal; Inflammation Mediators; Injections; Interleukin-1beta; Lipoxygenase Inhibitors; Mice; Models, Biological; Pain; Peripheral Nerve Injuries; Peripheral Nerves; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Touch; Tumor Necrosis Factor-alpha; Up-Regulation | 2010 |
Pain-releasing action of platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action.
Topics: Animals; Disease Models, Animal; Hyperalgesia; Male; Mice; Neuralgia; Pain Measurement; Peripheral Nerve Injuries; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Spinal Cord | 2013 |